Impact of relative contraindications on the use, benefits, and risks of anticoagulant prophylaxis in atrial fibrillation: analysis of a claims database

Journals Menu

Follow SCIRP

ISSN Print: 2162-5972
ISSN Online: 2162-5980
www.scirp.org/journal/ojim
E-mail: ojim@scirp.org

Citations h5-index & Ranking*

"Impact of relative contraindications on the use, benefits, and risks of anticoagulant prophylaxis in atrial fibrillation: analysis of a claims database"
written by Maneesha Mehra, Julia DiBello, Alan C. Fisher, Roger M. Mills,
published by Open Journal of Internal Medicine, Vol.1 No.3, 2011

has been cited by the following article(s):

[1]	Anticoagulação oral no idoso com Fibrilhação auricular
	2018

[2]	Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: Findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
	American heart journal, 2014

[3]	Copia autorizada por CDR
	NULL 2014

[4]	Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial …
	American Heart Journal, 2014

[5]	Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
	2013

[6]	CHA< sub> 2 DS< sub> 2-VASc and HASBLED scores: Implications for thromboembolic prophylaxis in the elderly with atri
	European Geriatric Medicine, 2013

[7]	Risks and Benefits of Anticoagulation in Atrial Fibrillation Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry
	Circulation: Cardiovascular Quality and Outcomes, 2013

[8]	CHA2DS2-VASc and HASBLED scores: Implications for thromboembolic prophylaxis in the elderly with atrial fibrillation
	NULL 2012

[1]	Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: Findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry American Heart Journal, 2014 DOI:10.1016/j.ahj.2013.12.014

[2]	Risks and Benefits of Anticoagulation in Atrial Fibrillation Circulation: Cardiovascular Quality and Outcomes, 2013 DOI:10.1161/CIRCOUTCOMES.113.000127

[3]	CHA2DS2-VASc and HASBLED scores: Implications for thromboembolic prophylaxis in the elderly with atrial fibrillation European Geriatric Medicine, 2013 DOI:10.1016/j.eurger.2012.10.004

Follow SCIRP